CLINICAL-EVALUATION OF THE BLOOD-GLUCOSE METERS ACCUTREND, COMPANION-2, GLUCOMETER-3, AND ONE-TOUCH-II AS COMPARED WITH THE REFERENCE GLUCOSE-OXIDASE METHOD
R. Weitgasser et al., CLINICAL-EVALUATION OF THE BLOOD-GLUCOSE METERS ACCUTREND, COMPANION-2, GLUCOMETER-3, AND ONE-TOUCH-II AS COMPARED WITH THE REFERENCE GLUCOSE-OXIDASE METHOD, Wiener Klinische Wochenschrift, 106(23), 1994, pp. 738-741
New small, light-weight and fast-acting meters for measuring blood glu
cose have been developed recently. To determine their accuracy and pre
cision we compared Accutrend, Companion 2, Glucometer 3 and One Touch
II with the reference glucose oxidase method. For determination of acc
uracy 150 measurements were performed on two meters of each brand, tog
ether with measurement on the Beckman 2 Analyzer, which served as our
reference. Capillary blood samples were obtained from patients with ty
pe 1 and type 2 diabetes attending our outpatient clinic. All measurem
ents were performed by one experienced technician. Precision in series
was determined by 15 measurements of venous EDTA samples. The coeffic
ient of variance was used for statistical analysis. Accuracy was evalu
ated according to recommendations of the American Diabetes Association
and clinically useful criteria such as the error grid analysis. We fo
und that One Touch II performed best overall, followed by Accutrend. C
ompanion 2 and Glucometer 3 showed higher deviations in both accuracy
and precision, but nonetheless met the clinical criteria of accuracy a
nd reliability measured by error grid analysis in 87% and 90.5% of mea
surements, respectively. In conclusion, all four blood glucose meters
can safely be used, after proper training, by patients and medical sta
ff for self-measurement of blood glucose.